Arcturus Therapeutics (ARCT) News Today $13.78 -0.70 (-4.83%) Closing price 04:00 PM EasternExtended Trading$14.14 +0.37 (+2.65%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock ARCT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Arcturus Therapeutics (NASDAQ:ARCT) Lowered to Sell Rating by Wall Street ZenJuly 5, 2025 | americanbankingnews.comArcturus Therapeutics (NASDAQ:ARCT) Downgraded by Wall Street Zen to "Sell"July 5, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (ARCT) - Yahoo FinanceJuly 4, 2025 | finance.yahoo.comSumitomo Mitsui Trust Group Inc. Lowers Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)July 4, 2025 | marketbeat.comArcturus Therapeutics (NASDAQ:ARCT) Price Target Raised to $35.00 at ScotiabankJuly 2, 2025 | marketbeat.comArcturus Therapeutics: High Hopes, High Hurdles For Its mRNA PipelineJuly 2, 2025 | seekingalpha.comArcturus Therapeutics stock rises on positive OTC deficiency trial dataJune 30, 2025 | za.investing.comArcturus Therapeutics Stock Rises After Promising Mid-Stage Data for OTC Deficiency TreatmentJune 30, 2025 | msn.comArcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency ProgramJune 30, 2025 | businesswire.comArcturus Therapeutics (NASDAQ:ARCT) Stock Crosses Below 200 Day Moving Average - Time to Sell?June 27, 2025 | marketbeat.comVerve Therapeutics (VERV) was downgraded to a Hold Rating at William BlairJune 18, 2025 | theglobeandmail.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Recommendation of "Buy" by AnalystsJune 18, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by Bank of America Corp DEJune 12, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 11, 2025 | marketbeat.comHow mRNA technology is offering a potential solution for patients with rare diseasesJune 10, 2025 | bbc.comBCantor Fitzgerald Weighs in on ARCT FY2026 EarningsJune 10, 2025 | marketbeat.comSquarepoint Ops LLC Sells 22,752 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)June 9, 2025 | marketbeat.com27,231 Shares in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Bought by Green Alpha Advisors LLCJune 2, 2025 | marketbeat.comScotiabank Initiates Coverage of Arcturus Therapeutics Holdings (ARCT) with Sector Outperform RecommendationMay 29, 2025 | msn.comArcturus Therapeutics to Attend Upcoming Investor ConferencesMay 29, 2025 | businesswire.comArcturus Therapeutics (NASDAQ:ARCT) Now Covered by Analysts at ScotiabankMay 29, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Recommendation of "Buy" by BrokeragesMay 26, 2025 | marketbeat.comArcturus Therapeutics’ SWOT analysis: mRNA innovator’s stock faces pivotal yearMay 25, 2025 | investing.comArcturus Therapeutics (NASDAQ:ARCT) Upgraded at StockNews.comMay 24, 2025 | marketbeat.comWoodline Partners LP Has $13.69 Million Stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)May 24, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Acquired by MPM Bioimpact LLCMay 16, 2025 | marketbeat.comCanaccord Genuity Group Lowers Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $66.00May 15, 2025 | marketbeat.comArcturus Therapeutics (NASDAQ:ARCT) Releases Quarterly Earnings ResultsMay 14, 2025 | marketbeat.com296,045 Shares in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Bought by J. Goldman & Co LPMay 14, 2025 | marketbeat.comQ1 2025 Arcturus Therapeutics Holdings Inc Earnings CallMay 14, 2025 | uk.finance.yahoo.comArcturus signals extended cash runway into 2028 with strategic shift toward CF and OTC mRNA therapeuticsMay 12, 2025 | msn.comArcturus Therapeutics Holdings Inc. (ARCT) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comBalyasny Asset Management L.P. Acquires New Stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)May 12, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by Dimensional Fund Advisors LPMay 12, 2025 | marketbeat.comEarnings To Watch: Arcturus Therapeutics Holdings Inc (ARCT) Reports Q1 2025 ResultMay 9, 2025 | finance.yahoo.comArcturus Therapeutics (ARCT) to Release Quarterly Earnings on MondayMay 7, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Acquires 479,482 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)May 2, 2025 | marketbeat.comBoothbay Fund Management LLC Makes New $1 Million Investment in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)May 2, 2025 | marketbeat.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of "Buy" from AnalystsMay 1, 2025 | marketbeat.comSumitomo Mitsui Trust Group, Inc. Reduces Stake in Arcturus Therapeutics Holdings Inc.April 30, 2025 | gurufocus.comResearch Analysts Offer Predictions for ARCT Q1 EarningsApril 20, 2025 | marketbeat.comArcturus Therapeutics (ARCT) Gets a Hold from Leerink PartnersApril 17, 2025 | markets.businessinsider.comVanguard Group Inc. Grows Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)April 16, 2025 | marketbeat.comArcturus Therapeutics granted fast track designation for ARCT-2304 from FDAApril 11, 2025 | markets.businessinsider.comHigh Growth Tech Stocks To Watch In The US April 2025April 11, 2025 | finance.yahoo.comArcturus Therapeutics price target lowered to $45 from $71 at GuggenheimApril 11, 2025 | markets.businessinsider.comArcturus Gets FDA Fast-Track Designation for Pandemic Influenza A H5N1 VaccineApril 10, 2025 | marketwatch.comArcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1April 10, 2025 | finance.yahoo.comArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Rating of "Buy" by AnalystsApril 6, 2025 | marketbeat.comBank of New York Mellon Corp Sells 22,024 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)March 24, 2025 | marketbeat.com Get Arcturus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARCT and its competitors with MarketBeat's FREE daily newsletter. Email Address ARCT Media Mentions By Week ARCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARCT News Sentiment▼0.401.00▲Average Medical News Sentiment ARCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARCT Articles This Week▼34▲ARCT Articles Average Week Get Arcturus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biohaven News Evotec News 89BIO News Janux Therapeutics News ANI Pharmaceuticals News Edgewise Therapeutics News Mesoblast News Travere Therapeutics News CureVac News Calliditas Therapeutics AB (publ) News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARCT) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcturus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARCT Stock Alerts